|
ESWI Respiratory Virus Summit 2024
ESWI Respiratory Virus Summit 2024 recap video
The discussions highlighted the crucial role of prevention, treatment and access to immunisation programmes to raise awareness and decrease the cases of RSV hospitalisations and deaths of young children and older adults.
Time for Top Leaders to Join Pandemic Negotiations
Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.
European Patients’ Rights Day: Addressing skills shortage, medical desertification and job strain
Ahead of European Patients’ Rights Day, Mariano Votta, Director of Active Citizenship Network, discusses how the event will tackle the skills shortage, medical desertification and job strain in the healthcare sector.
European Immunization Week 2024: Prevent. Protect. Immunise
WHO European Region celebrates the European Immunization Week in April to promote awareness of the importance of immunisation in preventing diseases and protecting life.
COVID-19 Shows Why the World Needs a Pandemic Agreement
Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.
Overcoming the COVID-19 pandemic together and building a Health Union
In 2020, the world was hit by the worst pandemic of our generation. At the heart of the European Commission’s response to COVID-19 were cooperation and solidarity.
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Conclusions
Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Science Policy Interface debate
How to ensure/prepare for access to immunisation programmes
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Rapporteur from the RSVVW’ 2024 meeting in Mumbai
By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: What's in the pipeline?
Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Early Career Scientists
ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Diagnostics and Point of Care Testing
Keynote Lecture by Dexter Wiseman, Imperial College London